Policy Recommendations for Strengthening the Accelerated Approval Program for Oncology Drugs
Memo: Delivered to the U.S. Food and Drug Administration (FDA)
Substance Use Disorder
Policy
Addressing U.S. Opioid Epidemic Through Increasing Access to Methadone
Briefing: Presented to Staff of U.S. House of Representative
Print:
On March 21st, 2024, Ashish Thakrar, MD, MS, LDI Associate Fellow from the Perelman School of Medicine; Sarah S. Kawasaki, MD, Current OTP Medical Director Associate Professor of Medicine Penn State Health; Nicole O’Donnell, Project Manager Penn Center for Addiction Medicine & Policy (CAMP); and Julia Hinckley, JD, Director of Policy Strategy at LDI conducted a virtual briefing for a bipartisan group of staff from the U.S. House of Representatives regarding proposed Modernizing Opioid Treatment Access Act legislation to increase access to methadone to address the U.S. overdose epidemic. This team of experts outlined evidence suggesting that expanding who can prescribe methadone would reduce overdose deaths.
More on Policy at LDI
Estimated Overdose Deaths Due to the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Health Impacts of SNAP Provisions in the One Big Beautiful Bill Act
Research Memo: Delivered to House Speaker Mike Johnson and Majority Leader John Thune
Projected Mortality Impacts of the Budget Reconciliation Bill
Research Memo: Response to Request for Technical Assistance
Loss of Subsidized Drug Coverage and Mortality Following Medicaid Disenrollment: Translating our Findings and Implications for Medicaid Policy
Research Memo: Supplement to Response to Request for Technical Assistance
Medicaid’s Role in Health and the Health Care Landscape: Key Takeaways from LDI Researchers
Research Memo: Delivered to Staff of U.S. Senate Committee on Finance